Does the Use of a Tourniquet Influence Five-Year Outcomes Following Total Knee Arthroplasty?
The Journal of Arthroplasty · 2025
DOI: 10.1016/j.arth.2024.11.021 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Jonathan L Katzman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, NYU Langone Health, New York, New York. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Tourniquets, Blood Loss, Surgical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: A tourniquet is commonly used during total knee arthroplasty (TKA) to improve surgical field visibility and minimize blood loss. While the short-term effects of tourniquet use on postoperative outcomes have been studied extensively and found to be minimal, its influence on longer-term outcomes remains underexplored. This study examined tourniquet use in TKA with up to 5-year follow-up. METHODS: In this post hoc analysis of a randomized controlled trial, 227 patients who underwent primary TKA in the tourniquet (T) group (n = 112) or no tourniquet (NT) group (n = 115) were evaluated. Clinical outcomes and patient-reported outcome measures were compared between the two groups. RESULTS: The T group had non-significant trends toward reduced blood loss (131.8 versus 116.7 mL, P = 0.098) and shorter operative time (97.8 versus 95.7 minutes, P = 0.264), with slightly higher postoperative day one visual analog scale pain scores (3.1 versus 3.6, P = 0.197). Length of stay (2.0 versus 2.1 days, P = 0.837) and home discharge rate (88.7 versus 92.0%, P = 0.340) were comparable. The NT group had 3 90-day readmissions, while none occurred in the T group (2.7 versus 0%, P = 0.081). The active range of motion at the final follow-up was similar between groups (108.3 versus 106.5 degrees, P = 0.457). All-cause revision rates at 5 years were comparable between the NT and T groups (5.2 versus 3.6%, P = 0.546). Kaplan-Meier survivorship analysis revealed comparable aseptic implant survival at 5 years (P = 0.769). There were no significant differences in Knee injury and Osteoarthritis Outcome Score for Joint Replacement, Patient-Reported Outcomes Measurement Information System (PROMIS) pain intensity, PROMIS pain interference, or PROMIS physical health scores at 3 months, 1 year, and 5 years postoperatively. CONCLUSIONS: Using a tourniquet during primary TKA was not associated with differences in clinical or patient-reported outcomes at up to 5-year follow-up. These findings suggest that tourniquet use in TKA can be left to the surgeon's discretion. LEVEL OF EVIDENCE: III.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, NYU Langone Health, New York, New York.
Zitieren
APA
Katzman, J. L., Sandoval, C. G., Roof, M. A., Rozell, J. C., Meftah, M., & Schwarzkopf, R. (2025). Does the Use of a Tourniquet Influence Five-Year Outcomes Following Total Knee Arthroplasty?. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.11.021
Vancouver
Katzman JL, Sandoval CG, Roof MA, Rozell JC, Meftah M, Schwarzkopf R. Does the Use of a Tourniquet Influence Five-Year Outcomes Following Total Knee Arthroplasty?. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2024.11.021
BibTeX
@article{Katzman2025,
author = {Katzman, Jonathan L and Sandoval, Carlos G and Roof, Mackenzie A and Rozell, Joshua C and Meftah, Morteza and Schwarzkopf, Ran},
title = {Does the Use of a Tourniquet Influence Five-Year Outcomes Following Total Knee Arthroplasty?},
journal = {The Journal of Arthroplasty},
year = {2025},
doi = {10.1016/j.arth.2024.11.021}
}
EUVIMED